NCT07186959

Brief Summary

ndoscopic bariatric and metabolic therapies (EBMTs) have introduced more convenient, minimally invasive, and safe approaches to weight management. Mucosal ablation of the gastric fundus has been reported to limit fundic expansion and promote satiety; however, ablation can cause perforation, infection, bleeding, and other complications. To restrain fundic expansion while minimizing surgical trauma and preserving reversibility, an endoscopic gastric purse-string suturing (EGPSS) technique was developed to reduce gastric volume. This procedure may be suitable for short-term weight management. Safety and feasibility were demonstrated in a porcine model. The present study will evaluate the feasibility of EGPSS in participants with obesity and assess histological and physiological outcomes.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2024

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

September 11, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 22, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

1.5 years

First QC Date

September 11, 2025

Last Update Submit

September 16, 2025

Conditions

Keywords

obesityendoscopic bariatric and metabolic therapybariatric surgery

Outcome Measures

Primary Outcomes (1)

  • Percent Total Weight Loss (%TWL) measured by calibrated digital scale

    Body weight recorded using a calibrated digital scale (kg). %TWL calculated as (baselineweight-follow-upweight)÷baselineweight × 100%. Measurements obtained under fasting conditions, light clothing, no shoes.

    Baseline and 3 months post-procedure

Secondary Outcomes (6)

  • Percent Excess Weight Loss (%EWL) measured by calibrated digital scale

    Baseline and 3 months

  • Satiety score (100-mm Visual Analog Scale, VAS) after standardized liquid meal

    Baseline and 3 months

  • Gastric fundus volume (magnetic resonance imaging, MRI)

    Baseline and 3 months

  • Fasting plasma ghrelin and leptin (ELISA)

    Baseline and 3 months

  • Insulin resistance (HOMA-IR)

    Baseline and 3 months

  • +1 more secondary outcomes

Study Arms (1)

Operation group

EXPERIMENTAL

Patients will undergo endoscopic gastric purse-string suturing procedure under endoscope by skilled endoscopist

Procedure: endoscopic gastric purse-string suturing

Interventions

A dual-tail endoloop will be introduced into the stomach with endoscopic forceps, and will be secured to the gastric wall using endoscopic clips. An endoscope hook was used to tighten both tails of the endoloop until all the clips converged.

Operation group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a body mass index (BMI) of 24-35 kg / m²;
  • Patients accepted Lifestyle modifications, pharmacological interventions for weight loss which were unsuccessful or experienced a weight rebound;
  • Patients willing to loss weight;
  • Obese patients with metabolic disorders.

You may not qualify if:

  • Women who are planning to conceive, pregnant, or breastfeeding;
  • Patients who are suffering from severe organ failure requiring hospitalization;
  • Patients who have undergone gastrectomy;
  • Patients allergic to anesthetics.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The fifth Medical Center of Chinese PLA General Hospital

Beijing, Beijing Municipality, 100071, China

Location

Related Publications (4)

  • Bluher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019 May;15(5):288-298. doi: 10.1038/s41574-019-0176-8.

    PMID: 30814686BACKGROUND
  • Maselli DB, Donnangelo LL, Coan B, McGowan CE. How to establish an endoscopic bariatric practice. World J Gastrointest Endosc. 2024 Apr 16;16(4):178-186. doi: 10.4253/wjge.v16.i4.178.

    PMID: 38680199BACKGROUND
  • Simons M, Sharaiha RZ. Updates in metabolic bariatric endoscopy. Dig Endosc. 2024 Feb;36(2):107-115. doi: 10.1111/den.14633. Epub 2023 Aug 9.

    PMID: 37405807BACKGROUND
  • Vargas EJ, Rizk M, Gomez-Villa J, Edwards PK, Jaruvongvanich V, Storm AC, Acosta A, Lake D, Fidler J, Bharucha AE, Camilleri M, Abu Dayyeh BK. Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: a comparative prospective study. Gut. 2023 Jun;72(6):1073-1080. doi: 10.1136/gutjnl-2022-327816. Epub 2022 Oct 14.

    PMID: 36241388BACKGROUND

MeSH Terms

Conditions

ObesityLymphoma, Follicular

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsLymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Yan Liu

    Beijing 302 Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director, Head of Gastroenterology, Principal Investigator, Clinical Professor

Study Record Dates

First Submitted

September 11, 2025

First Posted

September 22, 2025

Study Start

July 1, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

September 22, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations